 Connection
Benjamin Click to Drug Monitoring
This is a "connection" page, showing publications Benjamin Click has written about Drug Monitoring.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.444 |
|
|
|
-
Haydek JP, Mohan R, Lew J, Oonk A, Cheng D, Ahmed W, Click B, Fennimore B, Gerich M, Patel SG, Wani S, Hou JK, Scott FI. Treat-to-Target Monitoring Adherence and Rates of Healthcare Utilization in Patients With Inflammatory Bowel Disease in a Regional Healthcare System. Clin Transl Gastroenterol. 2026 Jan 01; 17(1):e00942.
Score: 0.183
-
Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Rubin DT, Dubinsky MC, Regueiro M, Gazis D, Crawford JM, Long MD. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD. BMC Gastroenterol. 2022 Feb 19; 22(1):71.
Score: 0.140
-
Franco DL, Click B. Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze? Inflamm Bowel Dis. 2020 01 01; 26(1):112-113.
Score: 0.121
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|